Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Neurogene Inc. | 12,472 | reported | 26 Mar 2026 | tx 6+168,200−828 |
| Q32 Bio Inc. | 4,160 | reported | 03 Aug 2023 | tx 12+6,929−8,881 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 26 Mar 2026 | SALE | Neurogene Inc. | 828 | 21.89 USD | |
| 20 Feb 2026 | GRANT_AWARD | Neurogene Inc. | 4,900 | 0.00 USD | |
| 20 Feb 2026 | GRANT_AWARD | Neurogene Inc. | 29,600 | 0.00 USD | deriv |
| 26 Mar 2025 | GRANT_AWARD | Neurogene Inc. | 8,400 | 0.00 USD | |
| 26 Mar 2025 | GRANT_AWARD | Neurogene Inc. | 50,300 | 0.00 USD | deriv |
| 16 Jan 2024 | GRANT_AWARD | Neurogene Inc. | 75,000 | 0.00 USD | deriv |
| 03 Aug 2023 | EXERCISE | Q32 Bio Inc. | 4,644 | 0.00 USD | |
| 03 Aug 2023 | SALE | Q32 Bio Inc. | 436 | 1.39 USD | |
| 03 Aug 2023 | EXERCISE | Q32 Bio Inc. | 1,548 | 0.00 USD | |
| 03 Aug 2023 | SALE | Q32 Bio Inc. | 1,308 | 1.39 USD | |
| 03 Aug 2023 | EXERCISE | Q32 Bio Inc. | 387 | 0.00 USD | |
| 03 Aug 2023 | SALE | Q32 Bio Inc. | 109 | 1.39 USD | |
| 03 Aug 2023 | EXERCISE | Q32 Bio Inc. | 387 | — | deriv |
| 03 Aug 2023 | EXERCISE | Q32 Bio Inc. | 1,548 | — | deriv |
| 03 Aug 2023 | EXERCISE | Q32 Bio Inc. | 4,644 | — | deriv |
| 02 Aug 2023 | SALE | Q32 Bio Inc. | 99 | 1.31 USD | |
| 02 Aug 2023 | EXERCISE | Q32 Bio Inc. | 350 | 0.00 USD | |
| 02 Aug 2023 | EXERCISE | Q32 Bio Inc. | 350 | — | deriv |